Orris

80-Year-old male, known case of high hypertension and cervical lymphadenopathy secondary to unknown cause has presented with lower abdominal pain, lower abdominal mass, bilateral pedal pitting edema. Lateral effusion of the volume one liter. Patient has a complaint of SOB secondary to the pleural effusion. His ultrasound shows a neoplastic nodal mass. In the abdominal region. His PSA level is normal. He has no any urinary complaints. Despite, patient has bilateral pedal edema. Cervical lymphadenopathy and abdominal mass, which is concerning. What can be the differential diagnosis in this condition? And what can be the definitive diagnosis? What lab investigation should be run for this patient, and what should be the treatment?

Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Searching PubMed

lymphoma AND diagnosis

Searching the Web

NICE non-Hodgkin lymphoma diagnosis excision biopsy PET CT 2024

Finding Sources
Finding Sources
Finding Sources
Reading Web Page

https://www.nice.org.uk/guidance/ng52/chapter/recommendation…

This is a high-risk presentation needing urgent hospital assessment and hematology/oncology input. The combination of persistent cervical lymphadenopathy, a bulky abdominal nodal mass, pleural effusion, and bilateral pitting edema is most concerning for an advanced systemic malignancy, particularly lymphoma. A normal PSA and no urinary symptoms make prostate cancer less likely, but do not establish the diagnosis.

Most likely working diagnosis

Non-Hodgkin lymphoma (NHL), possibly an aggressive B-cell lymphoma such as diffuse large B-cell lymphoma, with bulky abdominal nodal disease and possible pleural involvement.
Why this fits:
  • Lymph nodes involved in two non-contiguous regions, cervical and abdominal
  • Nodal mass rather than an organ-based mass on ultrasound
  • Pleural effusion and dyspnea, which may represent malignant pleural disease or lymphatic obstruction
  • Bilateral pedal edema, possibly from compression of the inferior vena cava or iliac veins by retroperitoneal/abdominal lymphadenopathy
  • Older age and rapidly symptomatic bulky disease raise concern for aggressive lymphoma
This is only a clinical probability, not a definitive diagnosis. Lymphoma subtype determines treatment and cannot be inferred reliably from ultrasound, PSA, or symptoms alone.

Important differentials

  1. Non-Hodgkin lymphoma
    • Diffuse large B-cell lymphoma
    • Follicular lymphoma with transformation
    • Mantle-cell lymphoma
    • Other mature B-cell or T-cell lymphoma
  2. Hodgkin lymphoma
    • Less common at this age, but still possible.
  3. Metastatic solid malignancy with nodal spread
    • Lung cancer, particularly with malignant pleural effusion
    • Gastrointestinal malignancy: stomach, pancreas, colon
    • Renal/urothelial malignancy
    • Head and neck primary malignancy causing cervical nodes
    • Occult primary cancer
  4. Tuberculosis or other chronic infection
    • Tuberculous lymphadenitis and pleural effusion can mimic lymphoma, particularly in endemic settings.
    • HIV-associated infection or lymphoproliferative disease should also be considered.
  5. Leukemia/other hematologic malignancy
    • Chronic lymphocytic leukemia/small lymphocytic lymphoma, etc.
  6. Non-malignant explanation of edema/effusion coexisting with nodal disease
    • Heart failure due to hypertension/ischemic heart disease
    • Renal disease or nephrotic syndrome
    • Liver disease/hypoalbuminemia
    • Venous thrombosis or venous compression by the abdominal mass

Definitive diagnosis

The definitive diagnosis requires adequate tissue biopsy, preferably:
  • Excisional biopsy of the most accessible abnormal cervical lymph node, before chemotherapy or corticosteroids if the patient is stable.
  • If excision is unsafe or impractical, obtain an image-guided core needle biopsy of the cervical or abdominal mass with several large cores.
The specimen should be sent for:
  • Histopathology
  • Immunohistochemistry
  • Flow cytometry
  • Cytogenetics/FISH, particularly for high-grade B-cell lymphoma markers such as MYC, BCL2, and BCL6
  • Molecular/clonality testing if pathology remains uncertain
  • Microbiology studies if tuberculosis or infection is plausible
Excision biopsy is preferred for suspected NHL because it preserves lymph-node architecture and gives the pathologist enough material for classification. NICE lymphoma guidance recommends excision biopsy first, with core biopsy when surgical risk outweighs benefit. The NCI also reports higher definitive-diagnosis rates with excisional than core biopsy. NCI lymphoma summary

Immediate investigations

1. Assess current instability first

Because he has dyspnea with a large pleural effusion, obtain:
  • Vital signs, oxygen saturation, respiratory examination
  • ECG
  • Chest radiograph
  • Bedside chest ultrasound
  • Oxygen if hypoxemic
  • Urgent therapeutic and diagnostic thoracentesis if the effusion is causing significant respiratory compromise
If he has severe breathlessness, hypoxia, hypotension, or clinical tamponade-like physiology, this needs emergency management, not outpatient investigation.

2. Blood tests

  • Complete blood count with differential and peripheral smear
  • ESR and/or CRP
  • Serum LDH, uric acid, phosphate, potassium, calcium, creatinine
  • Urea, electrolytes, bicarbonate
  • Liver function tests including albumin
  • Coagulation profile
  • Blood group and screen
  • HIV test
  • Hepatitis B surface antigen, anti-HBc, hepatitis C antibody, especially before likely rituximab-containing therapy
  • Serum protein electrophoresis, immunoglobulins, and serum free light chains if plasma-cell disorder/myeloma is considered
  • BNP/NT-proBNP and echocardiography if heart failure is a likely contributor to edema/effusion
  • Urinalysis and urine protein-creatinine ratio to assess renal protein loss
  • Tuberculosis testing guided by local setting: sputum if pulmonary symptoms, pleural fluid ADA/AFB smear/culture/NAAT, and node tissue mycobacterial studies when indicated
LDH, uric acid, renal function, potassium, phosphate, and calcium are particularly important before treatment, because a bulky, high-grade lymphoma can develop tumor lysis syndrome once therapy begins.

3. Imaging and staging

  • Contrast-enhanced CT of neck, chest, abdomen, and pelvis to define nodal regions, compression of major veins/ureters, organ involvement, and possible solid primary tumor.
  • FDG PET-CT after pathology confirms a PET-avid lymphoma subtype, for staging and baseline response assessment.
  • Ultrasound Doppler of both lower limbs and possibly IVC/iliac veins to exclude DVT and demonstrate venous compression.
  • Echocardiogram before anthracycline-based chemotherapy, particularly in an 80-year-old with hypertension.
  • Bone marrow biopsy only if needed for staging, unexplained cytopenias, or when it would change management. PET-CT often provides major staging information. NCI staging guidance

4. Pleural fluid investigations

At thoracentesis, send pleural fluid for:
  • Cell count and differential
  • Protein and LDH with simultaneous serum protein and LDH, to apply Light criteria
  • Glucose and pH
  • Gram stain and bacterial culture
  • Cytology
  • Flow cytometry for lymphoma cells
  • AFB studies, TB culture/NAAT, and ADA where tuberculosis is plausible
  • Triglyceride if fluid appears milky or chylothorax is suspected
Pleural-fluid cytology can demonstrate malignant cells, but a negative result does not exclude lymphoma or malignancy. If suspicion remains high, image-guided pleural biopsy or thoracoscopy may be needed.

Treatment approach

Treatment should not be finalized until tissue diagnosis and staging are available.

Immediate symptomatic management

  • Admit if symptomatic, hypoxemic, frail, or clinically unstable.
  • Oxygen for hypoxemia.
  • Therapeutic thoracentesis for significant dyspnea, with fluid sent for diagnosis.
  • Manage volume overload only if clinically present. Diuretics may help if heart failure/renal retention contributes, but they do not treat venous obstruction from tumor.
  • Evaluate and treat DVT if found. If there is venous compression without thrombosis, management depends on the underlying malignancy and severity.
  • Treat pain and maintain nutrition.
  • Monitor renal function and electrolytes closely.

Avoid empiric corticosteroids before biopsy if possible

Steroids can rapidly shrink lymphoma and may make histopathology nondiagnostic. They should generally be deferred until adequate biopsy has been obtained.
Exception: if there is a life-threatening complication such as impending airway obstruction, spinal cord compression, severe SVC syndrome, or rapidly worsening organ compromise, urgent corticosteroids may be necessary after urgent specialist discussion and ideally after tissue acquisition.

If lymphoma is confirmed

Management depends on the subtype, stage, functional status, cardiac function, renal function, frailty, and patient goals.
  • Aggressive B-cell lymphoma, e.g. DLBCL: often treated with rituximab-containing immunochemotherapy. In a fit person this may include R-CHOP-type therapy, but in an 80-year-old it may need dose adjustment, pre-phase treatment, or an alternative regimen based on geriatric assessment and cardiac status.
  • Indolent lymphoma: observation, rituximab-based treatment, chemotherapy-immunotherapy, or radiotherapy may be chosen depending on symptoms and disease burden.
  • Hodgkin lymphoma: treated with a different regimen and requires precise histologic confirmation.
  • Tuberculosis: full anti-tuberculous treatment, not chemotherapy.
  • Metastatic solid cancer: management is based on the primary site, molecular pathology, performance status, and whether the pleural effusion is malignant.
If a bulky high-grade lymphoma is diagnosed, tumor-lysis prevention may require hydration, allopurinol or rasburicase in selected high-risk patients, and close inpatient biochemical monitoring during initial treatment.

Practical priority sequence

  1. Stabilize breathing and evaluate the pleural effusion.
  2. Perform diagnostic/therapeutic thoracentesis if clinically indicated.
  3. Obtain urgent CT neck-chest-abdomen-pelvis.
  4. Obtain an excisional cervical lymph-node biopsy or high-quality core biopsy without delay.
  5. Send tissue for morphology, immunohistochemistry, flow cytometry, cytogenetics/FISH, and infection studies when appropriate.
  6. Stage confirmed disease with PET-CT and selective marrow testing.
  7. Start subtype-specific therapy through hematology/oncology.
The key point is that “lymphoma with bulky abdominal adenopathy” is the leading diagnosis, but only tissue biopsy can make it definitive and guide safe treatment.
This is a shared conversation. Sign in to Orris to start your own chat.